ArticleFrontiers in oncology2024

Newly emerged ROS1 rearrangement in a patient with lung adenocarcinoma following resistance to immune checkpoint inhibitors: a case report.

Jian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.